SF-QUALIVEEN Turkish Validity and Reliability Study

Istanbul Aydın University63 enrolled

Overview

Urological dysfunction is common in patients with Multiple Sclerosis (MS) and its prevalence has been reported at a high rate of 32-97%. Bladder dysfunction is associated with a significant deterioration in the quality of life of people with MS. In chronic diseases such as MS, patients experiences need to be measured directly in order to have information about patients perceptions about the effect of the disease on quality of life. However, there are a small number of valid and reliable Turkish scales on this subject.SF-Qualiveen is a validated scale for patients with MS who assess the urinary-specific quality of life by examining the impact of a wide range of bladder problems.The aim of our study is to make the Turkish cultural adaptation, validity and reliability of the SF-Qualiveen scale.

The aim of this study is to reveal the Turkish cultural adaptation, validity and reliability of the SF-Qualiveen scale. In our study, Sf-Qualiveen and Urogenital Distress Inventory (UDI-6) scales will be used. Pre-testing will be done in 10 patients with multiple sclerosis.Then, the validity and reliability of the scale will be performed in 80 patients with multiple sclerosis.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Sclerosis

Interventions

Questionnaire administration validation and reliabilityOTHER

After the pre-test is completed, if necessary, arrangements will be made, and then the validity and reliability of SF-Qualiveen will be made in 80 individuals with Multiple Sclerosis.First of all, participants will be asked to complete two questionnaires (SF-Qualiveen and Urinary Distress Inventory). Two weeks after this assessment, they will be asked to respond to SF-Qualiveen again.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. age 18-65; 2. definitive diagnosis of MS according to McDonald criteria; 3. ability to read and write in Turkish. Exclusion Criteria: 1. acute attacks of MS (within 3 months); 2. cognitive impairment (Mini Mental test result 24 points and below); 3. any chronic disease other than MS; 4. active malignant tumors; 5. symptomatic urinary tract infections; 6. patients who changed treatment within the test-retest period.

Outcomes

Primary Outcomes

SF-Qualiveen score

To evaluate the impact of urological problems on quality of life

Time frame: Baseline

Secondary Outcomes

Urogenital Distress Inventory (UDI-6)

To assess problems caused by urinary symptoms